Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PdEGF) in classical Hodgkin lymphoma (HL).
- Resource Type
- Article
- Authors
- Mainou-Fowler, Tryfonia; Angus, Brian; Miller, Susan; Proctor, Stephen J.; Taylor, Penelope R. A.; Wood, Katrina M.
- Source
- Leukemia & Lymphoma. Feb2006, Vol. 47 Issue 2, p223-230. 8p. 3 Diagrams, 2 Charts.
- Subject
- *HODGKIN'S disease
*VASCULAR endothelial growth factors
*PLATELET-derived growth factor
*GROWTH factors
*BLOOD proteins
*LYMPHOMAS
*ONCOLOGY
- Language
- ISSN
- 1042-8194
There is little information to date regarding the role of angiogenesis in Hodgkin lymphoma (HL). The present study examines micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial growth factor (PdEGF) in lymph node biopsies of patients with HL at presentation and relapse. Using immunohistochemistry, the degree of new blood vessel formation and the expression of VEGF and PdEGF was assessed in Hodgkin-rich tissue. The micro-vessel density (MVD) increased with disease progression in seven out of 11 cases. Expression of VEGF was observed in endothelial cells (EC) of some micro-vessels and also in follicular dendritic cells. The Hodgkin/Reed-Sternberg (H-RS) cells as well as the inflammatory lymphocytes were negative for VEGF. Cytoplasmic or cytoplasmic and nuclear expression of PdEGF by the H-RS cells was observed in five of the 11 presentation cases. The expression of PdEGF increased with disease progression in seven cases. In conclusion, Hodgkin tissue shows prominent vascularization. The increased MVD and PdEGF expression with disease progression merits further investigation. [ABSTRACT FROM AUTHOR]